ATE297887T1 - Nervonsäurederivate,ihre herstellung und anwendung - Google Patents

Nervonsäurederivate,ihre herstellung und anwendung

Info

Publication number
ATE297887T1
ATE297887T1 AT00977695T AT00977695T ATE297887T1 AT E297887 T1 ATE297887 T1 AT E297887T1 AT 00977695 T AT00977695 T AT 00977695T AT 00977695 T AT00977695 T AT 00977695T AT E297887 T1 ATE297887 T1 AT E297887T1
Authority
AT
Austria
Prior art keywords
acid derivatives
production
nervoic
those compounds
nervoic acid
Prior art date
Application number
AT00977695T
Other languages
English (en)
Inventor
Keith Coupland
Yann Raoul
Original Assignee
Croda Int Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Croda Int Plc filed Critical Croda Int Plc
Application granted granted Critical
Publication of ATE297887T1 publication Critical patent/ATE297887T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/533—Monocarboxylic acid esters having only one carbon-to-carbon double bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/587—Monocarboxylic acid esters having at least two carbon-to-carbon double bonds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT00977695T 1999-11-24 2000-11-23 Nervonsäurederivate,ihre herstellung und anwendung ATE297887T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9927629.7A GB9927629D0 (en) 1999-11-24 1999-11-24 Compounds
PCT/GB2000/004453 WO2001038288A1 (en) 1999-11-24 2000-11-23 Nervonic acid derivatives, their preparation and use

Publications (1)

Publication Number Publication Date
ATE297887T1 true ATE297887T1 (de) 2005-07-15

Family

ID=10864957

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00977695T ATE297887T1 (de) 1999-11-24 2000-11-23 Nervonsäurederivate,ihre herstellung und anwendung

Country Status (11)

Country Link
US (1) US6664406B1 (de)
EP (1) EP1232139B1 (de)
JP (1) JP3993434B2 (de)
AT (1) ATE297887T1 (de)
AU (1) AU775643B2 (de)
CA (1) CA2391953C (de)
DE (1) DE60020873T2 (de)
ES (1) ES2242651T3 (de)
GB (2) GB9927629D0 (de)
NZ (1) NZ518961A (de)
WO (1) WO2001038288A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0112324D0 (en) * 2001-05-21 2001-07-11 Croda Int Plc Compounds
JP2006520803A (ja) * 2003-03-20 2006-09-14 イマジェネティックス， インコーポレイテッド エステル化脂肪酸組成物
ES2238924B1 (es) 2004-02-17 2006-12-01 Investread Europa, S.L. Uso del acido 2,5-dihidroxibencenosulfonico, en la fabricacion de medicamentos de aplicacion en el tratamiento de enfermedades angiodependientes.
US20080125485A1 (en) 2004-02-17 2008-05-29 Action Medicines Use of 2,5-Dihydroxybenzene Derivatives for Treating Actinic Keratosis
US20070149618A1 (en) 2004-02-17 2007-06-28 Action Medicines, S.L. Methods of use for 2,5-dihydroxybenzene sulfonic acid compounds for the treatment of cancer, rosacea and psoriasis
US7776914B2 (en) 2004-03-22 2010-08-17 Imagenetix, Inc. Esterified fatty acid composition
PT2056815E (pt) 2006-08-16 2013-04-03 Amderma Pharmaceuticals Llc Utilização de derivados de 2,5-dihidroxibenzeno para tratar dermatite
WO2008020039A2 (en) 2006-08-16 2008-02-21 Action Medicines, S.L. 2,5-dihydroxybenzene compounds for treating cancers and hematological dyscrasias
WO2008061334A1 (en) 2006-11-21 2008-05-29 National Research Council Of Canada Lunaria annua, cardamine graeca and teesdalia nudicaulis fae genes and their use in producing nervonic and eicosenoic acids in seed oils
FR2940281B1 (fr) 2008-12-22 2011-04-01 Fabre Pierre Dermo Cosmetique Ester de diol et d'acide gras polyinsature comme agent anti-acne
EP2550362B1 (de) 2010-03-25 2017-01-04 Oregon Health&Science University Cmv-glycoproteine und rekombinante vektoren
CA2832109C (en) 2011-06-10 2021-07-06 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
MY163331A (en) 2011-08-05 2017-09-15 Massachusetts Inst Technology Liquid-impregnated surfaces, methods of making and devices incorporating the same
JP5803424B2 (ja) * 2011-08-22 2015-11-04 Jnc株式会社 ビニル酢酸の製造方法、ビニル酢酸誘導体及びその製造方法
AU2012216792A1 (en) 2011-09-12 2013-03-28 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
BR112014023436B1 (pt) 2012-03-23 2021-05-04 Massachusetts Institute Of Technology recipiente tendo superfície impregnada com líquido e seu processo de fabricação
US9625075B2 (en) 2012-05-24 2017-04-18 Massachusetts Institute Of Technology Apparatus with a liquid-impregnated surface to facilitate material conveyance
US20130337027A1 (en) * 2012-05-24 2013-12-19 Massachusetts Institute Of Technology Medical Devices and Implements with Liquid-Impregnated Surfaces
EP2679596B1 (de) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 Env-proteinvariante
US20140178611A1 (en) 2012-11-19 2014-06-26 Massachusetts Institute Of Technology Apparatus and methods employing liquid-impregnated surfaces
KR20150086522A (ko) 2012-11-19 2015-07-28 메사추세츠 인스티튜트 오브 테크놀로지 액체-함침된 표면을 사용하는 장치 및 방법
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
EP2873423B1 (de) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
US9947481B2 (en) 2014-06-19 2018-04-17 Massachusetts Institute Of Technology Lubricant-impregnated surfaces for electrochemical applications, and devices and systems using same
EP3069730A3 (de) 2015-03-20 2017-03-15 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
EP3072901A1 (de) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
CN115466178B (zh) * 2021-06-11 2024-06-11 青岛海合生物科技有限公司 一种神经酸衍生物及其制备方法和应用
CN113495161B (zh) * 2021-09-07 2021-11-16 宝枫生物科技（北京）有限公司 用于诊断缺血缺氧性脑病补充神经酸起效的生物标志物及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69025922T2 (de) 1989-11-30 1996-10-02 Croda Int Plc Verwendung von nervonsäure und langkettiger fettsäuren zur behandlung demyelinisierender erkrankungen
MY118354A (en) * 1995-05-01 2004-10-30 Scarista Ltd 1,3-propane diol derivatives as bioactive compounds

Also Published As

Publication number Publication date
WO2001038288A1 (en) 2001-05-31
GB2357083A (en) 2001-06-13
EP1232139A1 (de) 2002-08-21
EP1232139B1 (de) 2005-06-15
NZ518961A (en) 2004-02-27
GB9927629D0 (en) 2000-01-19
JP2003514886A (ja) 2003-04-22
GB2357083B (en) 2002-06-19
GB0028525D0 (en) 2001-01-10
JP3993434B2 (ja) 2007-10-17
ES2242651T3 (es) 2005-11-16
US6664406B1 (en) 2003-12-16
DE60020873T2 (de) 2006-05-04
CA2391953C (en) 2007-03-27
DE60020873D1 (de) 2005-07-21
AU1533301A (en) 2001-06-04
CA2391953A1 (en) 2001-05-31
AU775643B2 (en) 2004-08-12

Similar Documents

Publication Publication Date Title
ATE297887T1 (de) Nervonsäurederivate,ihre herstellung und anwendung
CA2446944A1 (en) Anti-inflammatory and immunomodulatory amino acid derivatives, their preparation and use
NO20056007L (no) Dobbel NK1/NK3 antagonister for behandling av schizofreni
DE60238042D1 (de) Glycyrrhetinsäurederivate und ihre verwendung zur herstellung eines medikaments zur hemmung der 11-beta-hydroxysteroid dehydrogenase
WO2002100833A1 (fr) Inhibiteurs de rho kinase
CY1112800T1 (el) Η χρηση υποκαθιστουμενων κυανοπυρρολιδινων για τη θεραπεια της υπερλιπιδαιμιας
ATE374749T1 (de) Indol-derivate als antientzündungs wirkstoffe
MXPA04006322A (es) Derivados de 6-fluorobiciclo[3.1.0]hexano.
RS50140B (sr) Postupak za dobijanje perkihinina i njegova upotreba
EP1813270A4 (de) Proteininhibitoren der hsp90-familie
TW200504032A (en) New carboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions
IL148426A0 (en) α-HYDROXY ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
ATE154937T1 (de) Steroide zur behandlung von prostatisch- hypertrophe, ihre herstellung und verwendung
MXPA03011954A (es) Nuevos derivados de acido sulfonico.
IS7482A (is) Fjölhringa efnasambönd sem sterk alfa2-adrenóviðtakamótlyf
NO20024241D0 (no) Fremgangsmåte for fremstilling av citalopram
DK0453042T3 (da) Hidtil ukendte 2 9-disubstituerede 4H-pyhrido[1 2-a]pyridin-4-oner
YU30603A (sh) Derivati premošćenog piperazina
WO2003004497A1 (fr) Compose heterocyclique
ATE54910T1 (de) Substituierte tetrahydro-3-pyridincarbonsaeuren, ihre ester und amide als cholinergische mittel.
HUP0400545A2 (hu) Uro-szelektív alfa1-adrenoceptor gátlóanyagokként használatos 1,4-diszubsztituált piperazinszármazékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
ATE277010T1 (de) Bis-indolederivate und ihre verwendung als entzündungshemmende mittel
DE60107832D1 (en) Chromenylmethylpyrimidindiamine als antibakterielle wirkstoffe
WO2004028455A3 (en) Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof
DK1204658T3 (da) Benzofurylpiperazin-serotoninagonister

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1232139

Country of ref document: EP